The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those ...

HealthDay News — Overall, 9.8 percent of all incident type 2 diabetes (T2D) cases and 3.1 percent of incident cardiovascular disease (CVD) cases were attributable to sugar-sweetened beverages (SSBs) ...

Type 2 diabetes (T2D) had emerged as a significant global health threat, yet its precise causes and mechanisms remained unclear. Researchers conducted a retrospective study to identify gene expression ...

According to the Company, the generic product will launch immediately. The Food and Drug Administration (FDA) has approved Liraglutide Injection, the first generic version of Victoza ®. Liraglutide is ...

Mesoblast (ASX:MSB) was the top performer for the year up 835% (as of December 30). On December 18 Mesoblast announced that the US Food and Drug Administration (FDA) had finally approved its therapy ...

Soon after his parents gave the an 8-year-old Jeff Dunham a dummy as a present, he decided he was going to be the world’s best ventriloquist. After decades of grinding through teen talent shows ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Current epidemiological data show that type 2 diabetes (T2D) increases 2-3 times the risk of developing dementia, in comparison with non-diabetic population matched by age and other risk factors (1).

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

However, few studies have examined the effects of longer bouts of exercise in type 2 diabetes (T2D). Longer bouts may have a greater potential to affect glucagon, interleukin-6 (IL-6) and incretin ...